SCP-8544
Safe
~
medium confidence
SCP-8544
Expected annual
$66K
One-time setup
$106K
Annual recurring
$63K
Personnel
0.21
One-time capital/setup costs are moderate (~$105.5k) driven by secure hardware, vault/upgrades, contingency seed and optional research; recurring annual operating costs are modest (~$61.8k/yr) driven by staff wages (IT/medical/psychiatry), legal/cover expenses, and monitoring/logging. Major cost drivers are frequency of amnestic administrations and any triggered medical complications or research projects.
One-Time Capital Costs
Total: $106K
Annual Recurring Costs
Total: $63K/yr
Cost Scenarios
📊
Baseline
(baseline)
$63K/yr
Uneventful year with no rediscovery events; normal monitoring, maintenance, and staffing.
no rediscovery
routine audits and maintenance
🚨
Minor Incident
$74K/yr
Single rediscovery event requiring one amnestic administration and standard follow-up.
single rediscovery
one amnestic administration
standard post-amnestic follow-up
🚨
Frequent Rediscovery
$116K/yr
Multiple rediscoveries in one year trigger repeated amnestic administrations and a funded research response.
3+ rediscoveries
multiple amnestic administrations
triggered research project
🚨
Major Medical Complication
$102K/yr
A severe adverse medical reaction to amnesticization requiring hospitalization, specialist care, and contingency expenditures.
adverse reaction
hospitalization
specialist/evacuation
Personnel
0.21 total
| Role | Count | Notes |
|---|---|---|
| Sysadmin / Infosec | 0.08 | [#3] Fractional FTE for patching, integrity checks, key management, and audits (0.05–0.10 FTE). |
| On-site Psychiatrist | 0.03 | [#7] Portion of psychiatrist time allocated for monthly sessions and supervision (0.02–0.05 FTE). |
| Medical Technician / Nurse | 0.08 | [#10] Fractional FTE for administration/monitoring of amnestics and on-call duties (0.05–0.10 FTE). |
| On-call Physician / Medical Oversight | 0.02 | [#10] Physician oversight/on-call stipend coverage (fractional FTE-equivalent). |
Confidence Notes
Analyst notes provide detailed line items and reasonable ranges, enabling a mid-confidence estimate; uncertainty remains around true frequency of rediscovery events and scope of potential medical complications or research triggers, which could materially change annual costs.